Journal of Clinical Oncology, Vol 2, 1235-1244, Copyright © 1984 by American Society of Clinical Oncology

ARTICLES

Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration

RK Oldham, KA Foon, AC Morgan, CS Woodhouse, RW Schroff, PG Abrams, M Fer, CS Schoenberger, M Farrell and E Kimball

The murine antimelanoma monoclonal antibody, 9.2.27, was administered intravenously to eight patients with metastatic malignant melanoma. Biopsies of metastatic nodules clearly demonstrate the selective localization of this antibody on the melanoma cell surface with a dose- response relationship to the quantity of administered antibody. The antibody infusions were clinically well tolerated and the pharmacokinetics of the antibody and the antiglobulin responses are described. This study indicates that murine monoclonal antibodies have potential as selective targeting agents in the design of future therapeutic trials using monoclonal antibodies or conjugates thereof in the treatment of cancer.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. K. Oldham and R. O. Dillman Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress J. Clin. Oncol., April 10, 2008; 26(11): 1774 - 1777. [Full Text] [PDF]

				C. Erfurt, Z. Sun, I. Haendle, B. Schuler-Thurner, C. Heirman, K. Thielemans, P. van der Bruggen, G. Schuler, and E. S. Schultz Tumor-Reactive CD4+ T Cell Responses to the Melanoma-Associated Chondroitin Sulphate Proteoglycan in Melanoma Patients and Healthy Individuals in the Absence of Autoimmunity J. Immunol., June 15, 2007; 178(12): 7703 - 7709. [Abstract] [Full Text] [PDF]

				R. S. Faye, S. Aamdal, H. K. Hoifodt, E. Jacobsen, L. Holstad, E. Skovlund, and O. Fodstad Immunomagnetic Detection and Clinical Significance of Micrometastatic Tumor Cells in Malignant Melanoma Patients Clin. Cancer Res., June 15, 2004; 10(12): 4134 - 4139. [Abstract] [Full Text] [PDF]

				Y Li, M C Madigan, K Lai, R M Conway, F A Billson, R Crouch, and B J Allen Human uveal melanoma expresses NG2 immunoreactivity Br J Ophthalmol, May 1, 2003; 87(5): 629 - 632. [Abstract] [Full Text] [PDF]

				B. Wang, Y.-B. Chen, O. Ayalon, J. Bender, and A. Garen Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement PNAS, February 16, 1999; 96(4): 1627 - 1632. [Abstract] [Full Text] [PDF]

				R. O. Dillman Monoclonal Antibodies for Treating Cancer Ann Intern Med, October 1, 1989; 111(7): 592 - 603. [Abstract] [PDF]

				H. F. Sears, D. J. Bagli, D. Herlyn, E. DeFreitas, H. Suzuki, G. Steele, and H. Koprowski Human Immune Response to Monoclonal Antibody Administration Is Dose-Dependent Arch Surg, December 1, 1987; 122(12): 1384 - 1388. [Abstract] [PDF]